¥823 million loss from COVID-19 and ¥435 million employment adjustment subsidy
First written in FY2021-Q1. . Latest entry: FY2024.
7 other companies' latest entry also says "Other".
- FY2024Update on disease-related losses and subsidiesAnnual report
「Extraordinary income amounted to ¥27 million, mainly because the company recorded ¥26 million in gains from the reversal of provisions for store closure losses.」
The losses attributable to COVID-19 and substantial subsidy income recorded through the previous fiscal year were not recorded in the current fiscal year's income statement. - FY2023Update on disease-related losses and subsidiesAnnual report
「The company recorded ¥113 million in extraordinary income, mainly because it recognized ¥72 million in subsidy income for contributions related to local governments' requests to shorten operating hours.」
Compared with ¥1,875 million in losses attributable to COVID-19 and employment adjustment subsidies recorded in the previous fiscal year, the company recorded no infectious-disease-related losses in the current fiscal year, while subsidy income amounted to ¥72 million. - FY2023-Q2Update on disease-related losses and subsidiesAnnual report
「Employment adjustment subsidy 0 Subsidy income 72 Losses attributable to COVID-19 -」
For the cumulative first six months, the company recorded ¥0 million in employment adjustment subsidies and ¥72 million in subsidy income, and recorded no losses attributable to COVID-19. - FY2023-Q1Update on disease-related losses and subsidiesAnnual report
「Subsidy income 29」
For the cumulative first quarter, the company recorded ¥29 million in subsidy income as extraordinary income. The ¥551 million in losses attributable to COVID-19 recorded in the same period of the previous year was not recorded in the current quarter. - FY2022-Q3Update on disease-related losses and subsidiesAnnual report
「Employment adjustment subsidy 329 Subsidy income 2,750 Losses attributable to COVID-19 1,339」
For the cumulative nine-month period, the company recorded ¥329 million in employment adjustment subsidies and ¥2,750 million in subsidy income as extraordinary income, while recording ¥1,339 million in infectious-disease-related losses as extraordinary losses. - FY2022-Q2Update on disease-related losses and subsidiesAnnual report
「Extraordinary income included ¥321 million in employment adjustment subsidies and ¥2,511 million in subsidy income, while extraordinary losses included ¥1,221 million in losses attributable to COVID-19.」
For the cumulative first six months, the company recorded ¥321 million in employment adjustment subsidies and ¥2,511 million in subsidy income, including contributions for reduced operating hours and other measures, while recording ¥1,221 million in infectious-disease-related losses. - FY2022-Q1Update on disease-related losses and subsidiesAnnual report
「Extraordinary income included ¥130 million in employment adjustment subsidies and ¥1,171 million in subsidy income, while extraordinary losses included ¥551 million in losses attributable to COVID-19.」
In the current quarter, the company recorded ¥130 million in employment adjustment subsidies and ¥1,171 million in contributions from local governments and other sources as extraordinary income, and ¥551 million in infectious-disease-related losses as extraordinary losses. - FY2021Update on disease-related losses and subsidiesAnnual report
「Meanwhile, extraordinary income included ¥603 million in employment adjustment subsidies and ¥1,045 million in subsidy income, including contributions for reduced operating hours, resulting in total extraordinary income of ¥1,901 million for the fiscal year.」
The company recorded ¥603 million in employment adjustment subsidies and ¥1,045 million in contributions for reduced operating hours and other items, while losses attributable to the infectious disease amounted to ¥1,629 million. - FY2021-Q3Update on disease-related losses and subsidiesAnnual report
「Employment adjustment subsidy ¥454 million」
For the cumulative nine-month period, the company recorded ¥454 million in employment adjustment subsidies as extraordinary income and ¥823 million in losses attributable to COVID-19 as extraordinary losses. - FY2021-Q2Update on disease-related losses and subsidiesAnnual report
「Employment adjustment subsidy 449 Losses attributable to COVID-19 823」
The company recorded ¥449 million in employment adjustment subsidies as extraordinary income and ¥823 million in fixed costs and other expenses incurred during the temporary closure period as losses attributable to the infectious disease, recorded as extraordinary losses. - FY2021-Q1First statedAnnual report
「Employment adjustment subsidy ¥435 million」
The company newly disclosed that it recorded ¥435 million in employment adjustment subsidies related to the infectious disease as extraordinary income, and ¥823 million in personnel expenses, rent and other costs incurred during the temporary closure period as extraordinary losses attributable to COVID-19.